Peter C. Hollenhorst, Ph.D.
Affiliations: | 2010- | Medical Sciences | Indiana University, Bloomington, Bloomington, IN, United States |
Area:
Biochemistry, Molecular BiologyGoogle:
"Peter Hollenhorst"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Catherine A. Fox | grad student | 2002 | UW Madison | |
| (Evolutionarily conserved forkhead transcription factors, Fkh1p and Fkh2p, in the yeast Saccharomyces cerevisiae.) | ||||
| Barbara Graves | post-doc | 2003-2009 | University of Utah (FlyTree) | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Damayanti NP, Cordova RA, Rupert C, et al. (2024) TFE3-splicing factor fusions represent functional drivers and druggable targets in translocation renal cell carcinoma. Cancer Research |
| Greulich BM, Rajendran S, Downing NF, et al. (2023) A complex with poly(A) binding protein and EWS facilitates the transcriptional function of oncogenic ETS transcription factors in prostate cells. The Journal of Biological Chemistry. 105453 |
| Nicholas TR, Metcalf SA, Greulich BM, et al. (2021) Androgen signaling connects short isoform production to breakpoint formation at Ewing sarcoma breakpoint region 1. Nar Cancer. 3: zcab033 |
| Strittmatter BG, Jerde TJ, Hollenhorst PC. (2021) Ras/ERK and PI3K/AKT signaling differentially regulate oncogenic ERG mediated transcription in prostate cells. Plos Genetics. 17: e1009708 |
| Greulich BM, Plotnik JP, Jerde TJ, et al. (2021) Toll-like receptor 4 signaling activates ERG function in prostate cancer and provides a therapeutic target. Nar Cancer. 3: zcaa046 |
| Nicholas TR, Meng J, Greulich BM, et al. (2020) --A high-throughput screen identifies inhibitors of the interaction between the oncogenic transcription factor ERG and the cofactor EWS. Plos One. 15: e0238999 |
| Nicholas TR, Strittmatter BG, Hollenhorst PC. (2019) Oncogenic ETS Factors in Prostate Cancer. Advances in Experimental Medicine and Biology. 1210: 409-436 |
| Strittmatter BG, Hollenhorst P. (2019) Abstract 5257: Activation of the oncogene ERG by the Ras/ERK and PI3K/AKT pathways Cancer Research. 79: 5257-5257 |
| Nicholas T, Strittmatter B, Jerde T, et al. (2019) Mechanisms of ETS family transcription factors that promote prostate cancer European Urology Supplements. 18: e3040 |
| Budka JA, Ferris MW, Capone MJ, et al. (2018) Common ELF1 deletion in prostate cancer bolsters oncogenic ETS function, inhibits senescence and promotes docetaxel resistance. Genes & Cancer. 9: 198-214 |